Description
Overview
This kit combines two synthetic peptides in a single vial: BPC-157, a 15-amino-acid gastric-protein-derived fragment, and Thymosin Beta-4, a 43-amino-acid actin-binding peptide (products in this space are often marketed under the shorthand “TB-500”). Supplied strictly for laboratory research use. This kit contains 10 vials at a nominal 10 mg + 10 mg fill each (200 mg total peptide content per kit).
Technical Specifications
| BPC-157 CAS Number | 137525-51-0 |
| BPC-157 Formula / MW | C₆₂H₉₈N₁₆O₂₂ / 1419.54 g/mol |
| Thymosin Beta-4 CAS Number | 77591-33-4 |
| Thymosin Beta-4 Formula / MW | C₂₁₂H₃₅₀N₅₆O₄₈S / 4963.44 g/mol (43 aa) |
| Appearance | White lyophilized powder |
| Nominal Fill | 10 mg BPC-157 + 10 mg Thymosin Beta-4 / vial — 10 vials / kit |
Batch Certificate of Analysis
Every batch we sell is independently lab-tested before listing, with both peptide components confirmed and quantified separately. The figures below are from the current batch Certificate of Analysis — not marketing estimates.
| Batch / Lot | Blue Cap |
| Accession # | SPB2609010406 |
| Combined Purity | 99.32% |
| Verified BPC-157 Content | 5.58 mg (tested vial) |
| Verified Thymosin Beta-4 Content | 6.02 mg (tested vial) |
| Identity Confirmation | Both peptides confirmed via LC-MS |
| Testing Laboratory | FreedomDiagnosticsTesting.com |
| Report Date | September 3, 2026 |
View the full Certificate of Analysis (PDF)
Storage & Handling
Ship and store lyophilized powder at -20°C. Reconstitute with bacteriostatic or sterile water immediately before use; once reconstituted, keep refrigerated at 2–8°C and use promptly. Avoid repeated freeze-thaw cycles and prolonged light exposure.
Research Use Only
This product is sold exclusively for in-vitro laboratory and preclinical research use by qualified professionals. It is not a drug, food, cosmetic, or dietary supplement, and is not intended for human or veterinary use, diagnosis, treatment, or prevention of any disease. Not for human consumption.
Reviews
There are no reviews yet.